Caminero JA - Search Results

1

Impact of COVID-19 on tuberculosis services in India.

Gupta A, Singla R, Caminero JA, Singla N, Mrigpuri P, Mohan A. Gupta A, et al. Among authors: caminero ja. Int J Tuberc Lung Dis. 2020 Jun 1;24(6):637-639. doi: 10.5588/ijtld.20.0212. Int J Tuberc Lung Dis. 2020. PMID: 32553014 No abstract available.

2

The epidemiology of tuberculosis in Gran Canaria, Canary Islands, 1988-92: effectiveness of control measures.

Caminero JA, Díaz F, Rodríguez de Castro F, Pavón JM, Esparza R, Cabrera P. Caminero JA, et al. Tuber Lung Dis. 1995 Oct;76(5):387-93. doi: 10.1016/0962-8479(95)90003-9. Tuber Lung Dis. 1995. PMID: 7495998

3

Evaluation of tuberculosis trends in Spain, 1991-1999.

Caminero JA, Caylà JA, Lara N; Working Group on the Current Status of Tuberculosis in Spain. Caminero JA, et al. Int J Tuberc Lung Dis. 2003 Mar;7(3):236-42. Int J Tuberc Lung Dis. 2003. PMID: 12661837

4

Is the DOTS strategy sufficient to achieve tuberculosis control in low- and middle-income countries? 1. Need for interventions in universities and medical schools.

Caminero JA. Caminero JA. Int J Tuberc Lung Dis. 2003 Jun;7(6):509-15. Int J Tuberc Lung Dis. 2003. PMID: 12797691 Review.

5

Is the DOTS strategy sufficient to achieve tuberculosis control in low- and middle-income countries? 2. Need for interventions among private physicians, medical specialists and scientific societies.

Caminero JA. Caminero JA. Int J Tuberc Lung Dis. 2003 Jul;7(7):623-30. Int J Tuberc Lung Dis. 2003. PMID: 12870682

6

A 6-month regimen for EPTB with intermittent treatment in the continuation phase: a study of 679 cases.

Caminero JA, Fuentes ZM, Martín TY, España M, Istúriz GJ, Millán EA, Alfonzo E, Castillo OY, Cabrera P, Guilarte A. Caminero JA, et al. Int J Tuberc Lung Dis. 2005 Aug;9(8):890-5. Int J Tuberc Lung Dis. 2005. PMID: 16104636

7

Treatment of multidrug-resistant tuberculosis: evidence and controversies.

Caminero JA; World Health Organization; American Thoracic Society; British Thoracic Society. Caminero JA, et al. Int J Tuberc Lung Dis. 2006 Aug;10(8):829-37. Int J Tuberc Lung Dis. 2006. PMID: 16898365 Review.

8

Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome.

Rusen ID, Aït-Khaled N, Alarcón E, Billo N, Bissell K, Boillot F, Caminero J, Chiang CY, Clevenbergh P, Dhliwayo P, Dlodlo R, Enarson DA, Ferroussier O, Fujiwara PI, Heldal E, Hinderaker SG, Kim SJ, Lienhardt C, Rieder HL, Trébucq A, Van Deun A, Wilson N. Rusen ID, et al. Int J Tuberc Lung Dis. 2007 Feb;11(2):120-1. Int J Tuberc Lung Dis. 2007. PMID: 17263279 No abstract available.

9

Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.

Caminero JA. Caminero JA. Int J Tuberc Lung Dis. 2008 Aug;12(8):869-77. Int J Tuberc Lung Dis. 2008. PMID: 18647445

10

Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.

Chiang CY, Caminero JA, Enarson DA. Chiang CY, et al. Among authors: caminero ja. Int J Tuberc Lung Dis. 2009 May;13(5):548-50. Int J Tuberc Lung Dis. 2009. PMID: 19383184 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters